Can You Get PCOS Later in Life?

Can you get PCOS later in life? While polycystic ovary syndrome most commonly emerges around puberty, many women receive their diagnosis in their 30s or 40s, not because the condition appeared suddenly, but because symptoms were previously mild, masked by hormonal contraception, or simply not investigated. PCOS affects around 1 in 10 women in the UK and carries long-term metabolic and cardiovascular implications that remain relevant beyond the reproductive years. Understanding why symptoms surface later, how diagnosis works in older women, and what treatment options are available through the NHS can help you seek the right support at any age.

Can you develop PCOS later in life?

PCOS can be diagnosed later in life, but the hormonal imbalance typically dates from puberty; a later diagnosis usually means symptoms were previously mild, misattributed, or uninvestigated rather than newly developed.

Polycystic ovary syndrome (PCOS) can be diagnosed later in life, though in most cases the underlying hormonal imbalance has been present since puberty or early adulthood. PCOS is a long-term condition affecting how the ovaries work, characterised by elevated androgens (male hormones), irregular ovulation, and, in many women, multiple small follicles visible on ultrasound. It is one of the most common hormonal conditions in women of reproductive age, with the NHS estimating it affects around 1 in 10 women in the UK.

The reason some women receive a diagnosis in their 30s or 40s is not that the condition appeared suddenly, but rather that symptoms were previously mild, misattributed to other causes, or simply not investigated. A woman who had irregular periods in her teens may have been told this was normal, only to seek further assessment years later when trying to conceive or when symptoms become more pronounced.

PCOS is typically diagnosed before menopause. After menopause, the hormonal shifts mean that the standard diagnostic criteria are difficult to apply reliably, and a new diagnosis of PCOS is not usually made at that stage. However, the metabolic and cardiovascular risks associated with PCOS, including a higher likelihood of type 2 diabetes and dyslipidaemia, persist beyond menopause and should continue to be monitored.^[12][13] Women who have never been diagnosed but carry the underlying hormonal profile may first come to medical attention during perimenopause, when symptoms become more apparent.

Important: any vaginal bleeding after menopause requires urgent assessment and should not be attributed to PCOS. Contact your GP promptly, as this warrants investigation through an urgent referral pathway. If you have concerns about symptoms that could suggest PCOS at any age, speaking to your GP is the appropriate first step, as they can arrange relevant investigations and refer you to a specialist if needed.

Why do some women notice PCOS symptoms in their 30s and 40s?

Stopping hormonal contraception, weight gain worsening insulin resistance, and perimenopausal hormonal fluctuations can all unmask or amplify pre-existing PCOS symptoms for the first time in a woman's 30s or 40s.

Several life events and hormonal changes in a woman's 30s and 40s can bring PCOS symptoms to the foreground for the first time. One of the most common triggers is stopping hormonal contraception, particularly the combined oral contraceptive pill, which can mask PCOS symptoms by regulating periods, reducing androgen levels, and suppressing the hormonal irregularities that define the condition. It is important to note that blood tests for androgens and SHBG, as well as pelvic ultrasound for ovarian morphology, are generally unreliable while taking combined hormonal contraception. Assessment is usually deferred for around three months after stopping, so that results can be interpreted accurately. When contraception is stopped, often when trying to conceive, the underlying pattern may reassert itself and prompt investigation.

Weight changes are another significant factor. PCOS and insulin resistance are closely linked, and weight gain in the 30s and 40s, whether related to lifestyle, stress, or other hormonal shifts, can worsen insulin resistance and amplify symptoms such as irregular periods, acne, and excess hair growth. Conversely, some women with a lean body type may have had subclinical symptoms for years that only become clinically apparent as their hormonal environment shifts.

Perimenopause, which can begin in the early to mid-40s, introduces its own hormonal fluctuations that may interact with the pre-existing androgen excess of PCOS. Some women find that symptoms such as hair thinning, mood changes, and metabolic difficulties become more noticeable during this period. Distinguishing PCOS-related symptoms from perimenopausal changes requires careful clinical assessment, as the two conditions can overlap and share features.

If you are trying to conceive and are aged 36 or over, it is advisable to seek a fertility assessment after around six months of trying without success, rather than waiting the usual twelve months recommended for younger women.^[7][8] If your cycles are very infrequent (fewer than eight per year), seek assessment sooner regardless of age. Rapid-onset hirsutism, a deepening voice, or other signs of significant androgen excess should prompt urgent specialist referral rather than routine monitoring. Keeping a record of your menstrual cycle, any new or worsening symptoms, and relevant family history can be very helpful when discussing your concerns with a GP.

How is PCOS diagnosed in older women by UK doctors?

UK doctors diagnose PCOS using the Rotterdam criteria, requiring at least two of three features: irregular ovulation, androgen excess, and polycystic ovarian morphology, after excluding other conditions such as thyroid disease and hyperprolactinaemia.

PCOS is diagnosed using the Rotterdam criteria, which require at least two of the following three features: irregular or absent ovulation, clinical or biochemical signs of elevated androgens, and polycystic ovarian morphology on ultrasound. Crucially, other conditions that can cause similar features must be excluded before a diagnosis of PCOS is confirmed. These include thyroid disease, hyperprolactinaemia, non-classic congenital adrenal hyperplasia (assessed via 17-hydroxyprogesterone), Cushing's syndrome, pregnancy, and, where androgen excess is severe or rapid in onset, an androgen-secreting tumour.

A GP or gynaecologist will take a detailed history, including menstrual patterns, symptoms of androgen excess, and any relevant family history, before arranging investigations.

Blood tests typically include:

• Total testosterone and sex hormone-binding globulin (SHBG): used together to calculate the free androgen index, which is the preferred approach in UK practice for identifying androgen excess; SHBG alone can be informative, as low levels may indicate androgen excess even when total testosterone appears normal

• Luteinising hormone (LH) and follicle-stimulating hormone (FSH): measured to help exclude other causes and, in women approaching perimenopause, to help distinguish PCOS-related irregularities from menopausal transition; note that the LH to FSH ratio is not recommended as a diagnostic criterion for PCOS in current UK guidance^[6][9]

• HbA1c: the standard first-line test to screen for type 2 diabetes risk in most women with PCOS; an oral glucose tolerance test (OGTT) may be preferred in certain higher-risk situations, such as a strong family history of diabetes or previous gestational diabetes, and your GP can advise which is appropriate for you^[2][6]

• Thyroid function tests and prolactin: to exclude other conditions that can cause similar symptoms

• Blood pressure and a fasting lipid profile: as part of routine cardiometabolic risk assessment, which is an important component of PCOS care

Pelvic ultrasound remains a useful diagnostic tool, though ovarian morphology becomes less specific with age and should always be interpreted alongside clinical and biochemical findings rather than in isolation. The threshold for what constitutes polycystic ovarian morphology was updated in the 2023 international evidence-based PCOS guideline, and UK clinicians are increasingly applying these revised criteria.^[2][3]

NICE Clinical Knowledge Summary (CKS) on PCOS provides a framework for assessment and management in primary care. If your GP suspects PCOS, they may manage initial investigations themselves or refer you to a gynaecologist or endocrinologist, depending on the complexity of your presentation.

What symptoms should you look out for as you get older?

Key symptoms to monitor include irregular periods, hirsutism, androgenic hair thinning, persistent acne, abdominal weight gain, and skin changes such as acanthosis nigricans, alongside longer-term risks of type 2 diabetes and dyslipidaemia.

Women with PCOS in their 30s and 40s may experience a range of symptoms that differ in emphasis from those seen in younger women. The most clinically significant symptoms to be aware of include:

• Irregular or absent periods: cycles that are consistently longer than 35 days, or fewer than eight periods per year, warrant investigation

• Excess hair growth (hirsutism): coarse hair appearing on the face, chest, abdomen, or back, driven by elevated androgens

• Hair thinning or loss: androgenic alopecia, particularly at the crown or temples, can become more noticeable with age

• Persistent acne: particularly along the jawline and chin in adult women

• Weight gain or difficulty losing weight: especially around the abdomen, often linked to insulin resistance

• Mood changes: anxiety and low mood are more common in women with PCOS, though the mechanisms are not fully understood^[18][19]

• Skin changes: darkened patches of skin (acanthosis nigricans) in skin folds can indicate insulin resistance

Longer-term health risks associated with PCOS that become increasingly relevant with age include a higher likelihood of developing type 2 diabetes, elevated blood pressure, and dyslipidaemia. Women with PCOS who experience prolonged periods of absent menstruation (amenorrhoea) may also be at increased risk of endometrial hyperplasia due to unopposed oestrogen, and this should be discussed with a GP.^[15][16]

When to seek help urgently or promptly:

• Any vaginal bleeding after menopause requires urgent assessment; contact your GP promptly so that an urgent referral can be arranged if needed

• Persistent bleeding between periods, or very heavy periods, should be assessed promptly rather than attributed to PCOS alone

• Amenorrhoea lasting more than three months warrants a GP review

• Rapid-onset or severe hirsutism, a deepening voice, or other signs of significant androgen excess should prompt urgent specialist referral

If you notice several of these symptoms together, or if existing symptoms are worsening, contact your GP rather than attributing changes solely to ageing or perimenopause. Early assessment allows for timely management and reduces longer-term health risks.

Treatment and support options available through the NHS

NHS management of PCOS combines lifestyle modification as first-line treatment with medical options including the combined pill, progestogen therapy, metformin, and letrozole for ovulation induction, tailored to each woman's symptoms and goals.

PCOS has no cure, but its symptoms and associated health risks can be effectively managed through a combination of lifestyle measures and medical treatment, all of which are available through the NHS. NICE guidance and the 2023 international evidence-based PCOS guideline both recommend that lifestyle modification, particularly achieving or maintaining a healthy weight through a balanced diet and regular physical activity, is the first-line approach for most women. Even modest weight loss can improve hormonal balance, menstrual regularity, and metabolic markers, though the degree of benefit varies between individuals.

Medical treatments your GP or specialist may consider include:

• Combined oral contraceptive pill: to regulate periods and reduce androgen-related symptoms such as acne and hirsutism, where contraception is also desired or acceptable

• Progestogen therapy or the levonorgestrel intrauterine system (LNG-IUS): to induce regular withdrawal bleeds and protect the endometrium in women with infrequent periods; the LNG-IUS is a suitable option where long-term contraception is also acceptable

• Metformin: an insulin-sensitising medicine that may be considered for women with PCOS where lifestyle measures have been insufficient, particularly where there is evidence of insulin resistance or metabolic risk; your GP or specialist can advise whether it is appropriate for you^[5][6]

• Eflornithine cream or referral for laser hair removal: for management of facial hirsutism; NHS provision of laser hair removal is limited and varies by area, so discuss availability and referral criteria with your GP

• Letrozole: current UK guidance recommends letrozole as the first-line treatment for ovulation induction in women with anovulatory PCOS who are trying to conceive; clomifene may be considered as an alternative where letrozole is unsuitable or unavailable, and referral to a fertility specialist is appropriate for further assessment and treatment^[10][11]

For women whose weight is significantly affecting their PCOS symptoms and overall health, a GP may discuss referral to a specialist weight management service. Online consultations with a GPhC-registered pharmacy such as Bolt Pharmacy can provide access to prescriber-led weight management assessments, where a clinician may consider a range of options if clinically appropriate. Psychological support, including cognitive behavioural therapy (CBT) available through NHS Talking Therapies, can also be beneficial given the impact PCOS can have on mood and self-esteem.

Scientific References

1. Polycystic ovary syndrome (PCOS).
2. Recommendations From the 2023 International Evidence-Based Guideline for the Assessment and Management of PCOS.
3. Recommendations from the 2023 international evidence-based guideline for the assessment and management of PCOS (full guideline).
4. Polycystic ovary syndrome: metformin in women not planning pregnancy (ESUOM6) — What is polycystic ovary syndrome?.
5. Polycystic ovary syndrome: metformin in women not planning pregnancy (ESUOM6) — About metformin.
6. Polycystic ovary syndrome | Treatment summaries — BNF.
7. Fertility problems: assessment and treatment (NG257).
8. Fertility problems: referral for specialist consultation (QS73).
9. Polycystic ovary syndrome (GID-NG10436): draft scope.
10. Polycystic ovary syndrome: adaptation report 5 (GID-NG10436) — letrozole as first-line ovulation induction.
11. Polycystic ovary syndrome (GID-NG10436): document 450 — ovulation induction.
12. From PCOS to PMOS: An EMAS clinical guide to the proposed terminology and its relevance to menopause care. Maturitas..
13. Evolution of cardiovascular risk factors and the risk for cardiovascular events in a Caucasian population with polycystic ovary syndrome. European Journal of Endocrinology..
14. Long-term health outcomes in young women with polycystic ovary syndrome: A narrative review. Clinical Endocrinology..
15. Screening for endometrial hyperplasia and endometrial cancer in premenopausal women with PCOS. BMJ Open..
16. Cancer risk and PCOS. Steroids..
17. Ultrasonographic criteria in the diagnosis of polycystic ovary syndrome: a systematic review and diagnostic meta-analysis. Human Reproduction Update..
18. Yoga as a complementary intervention for polycystic ovary syndrome management: a systematic review. Frontiers in Reproductive Health..
19. Depression and anxiety among women with polycystic ovarian syndrome in low- and middle-income countries: a systematic review and meta-analysis. Frontiers in Global Women's Health..
20. Prevalence and outcomes of co-occurring psychiatric and endocrine, metabolic, and nutritional disorders: An atlas based on umbrella review. European Neuropsychopharmacology..

Frequently Asked Questions